title: The application of contrast agents in the evaluation of neoplasms of the central nervous system.
abstract: Magnetic resonance evaluation of central nervous system neoplasms has improved tremendously since the introduction of gadolinium-based contrast agents. The optimal application of these agents in clinical imaging, however, has not been well established. The article discusses the recent application of these agents to a number of intracranial neoplasms, including metastases, gliomas, pituitary adenomas, and acoustic neurinomas/cerebellopontine angle tumors.
authors.affiliation: Department of Radiology, University of Iowa College of Medicine, Iowa City.
authors.forename: W T
authors.initials: WT
authors.lastname: Yuh
authors.forename: D J
authors.initials: DJ
authors.lastname: Fisher
authors.forename: H D
authors.initials: HD
authors.lastname: Nguyen
authors.forename: E T
authors.initials: ET
authors.lastname: Tali
authors.forename: N A
authors.initials: NA
authors.lastname: Mayr
mesh_terms: D001932:Brain Neoplasms / Q000175:diagnosis* / Q000556:secondary; D002528:Cerebellar Neoplasms / Q000175:diagnosis; D002530:Cerebellopontine Angle; D003287:Contrast Media; D005682:Gadolinium; D019786:Gadolinium DTPA; D005910:Glioma / Q000175:diagnosis; D006801:Humans; D008279:Magnetic Resonance Imaging; D009464:Neuroma, Acoustic / Q000175:diagnosis; D009942:Organometallic Compounds; D004369:Pentetic Acid; D010911:Pituitary Neoplasms / Q000175:diagnosis
chemical_list: D003287:Contrast Media; D009942:Organometallic Compounds; D004369:Pentetic Acid; D005682:Gadolinium; D019786:Gadolinium DTPA